T 46 (Clorazepate 7.5 mg)

Pill imprint T 46 has been identified as Clorazepate dipotassium 7.5 mg.

Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 7.5 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Imprint Search

Images for T 46

Clorazepate dipotassium 7.5 mg T 46
Clorazepate dipotassium 7.5 mg T 46
Clorazepate dipotassium
Imprint:
T 46
Strength:
7.5 mg
Color:
Orange
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Benzodiazepines
Pregnancy Category:
N - Not classified
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Taro Pharmaceuticals U.S.A., Inc.
National Drug Code (NDC):
51672-4043
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
potassium chloride
magnesium silicate
D&C Red No. 6
aluminum oxide
D&C Yellow No. 10
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
67544-0579 Prepak Systems Inc (repackager)
68258-7012 Dispensing Solutions Inc. (repackager)
60429-0528 Golden State Medical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)